GLYMPSE BIO
Glympse Bio develops a powerful new paradigm in diagnostics to enable noninvasive and predictive monitoring of multiple human diseases. The company’s technology uses precisely engineered diagnostic agents that interrogate the body for certain disease states, and then carry the message to the urine for analysis. Glympse Bio’s platform technology was originally developed at MIT, and is founded by a team of world-renowned experts in nanomedicine and biomedical engineering.
GLYMPSE BIO
Industry:
Biotechnology Health Care Life Science Medical Device Nanotechnology
Founded:
2015-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.glympsebio.com
Total Employee:
11+
Status:
Active
Contact:
617-863-3636
Email Addresses:
[email protected]
Total Funding:
93.3 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Font Awesome
Similar Organizations
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Demetrix
Demetrix is a biotechnology company dedicated to researching and producing bioactive ingredients.
Flare Therapeutics
Flare Therapeutics is a biotechnology company targeting transcription factors to discover precision medicines for cancer and other diseases.
LunaPBC
LunaPBC is a healthcare company that transforms health data into health breakthroughs.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Temasek Holdings
Temasek Holdings investment in Series B - Glympse Bio
New Leaf Venture Partners
New Leaf Venture Partners investment in Series B - Glympse Bio
LS Polaris Innovation Fund
LS Polaris Innovation Fund investment in Series B - Glympse Bio
CRV
CRV investment in Series B - Glympse Bio
Catalio Capital Management
Catalio Capital Management investment in Series B - Glympse Bio
Gilead Sciences
Gilead Sciences investment in Series B - Glympse Bio
GreatPoint Ventures
GreatPoint Ventures investment in Series B - Glympse Bio
Section 32
Section 32 investment in Series B - Glympse Bio
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Glympse Bio
DNS Capital
DNS Capital investment in Series B - Glympse Bio
Key Employee Changes
| Date | New article |
|---|---|
| 2022-05-17 | Glympse Appoints Jonathan Wilde, Ph.D., as Chief Scientific Officer to Advance Biosensor Assay Platform |
Official Site Inspections
http://www.glympsebio.com Semrush global rank: 5.51 M Semrush visits lastest month: 1.55 K
- Host name: 233.151.226.35.bc.googleusercontent.com
- IP address: 35.226.151.233
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
